Status:
TERMINATED
AcQMap® US Registry of Procedural and Long-term Clinical Outcomes (Discover-US)
Lead Sponsor:
Acutus Medical
Conditions:
Ablation of Arrhythmia's
Eligibility:
All Genders
18-80 years
Brief Summary
AcQMap Registry is an observation study
Detailed Description
AcQMap Registry is an observational, prospective, multi-center, open-label registry designed to provide clinical data regarding the commercial, real-life experience with the diagnostic AcQMap System.
Eligibility Criteria
Inclusion
- Male or female 18 years of age or older. Currently scheduled for an ablation of an arrhythmia utilizing the diagnostic AcQMap System.
- Willingness, ability and commitment to participate in baseline and follow-up evaluations for the full length of the study.
- Willing and able to give written informed consent.
Exclusion
- In the opinion of the Investigator, any known contraindications to an ablation procedure.
- Current enrollment in any study protocol sponsored by Acutus Medical. Any other condition that, in the judgment of the investigator, makes the participant a poor candidate for this procedure, the study, or compliance with the protocol (includes vulnerable patient population, mental illness, addictive disease, extensive travel away from the research center, etc.).
Key Trial Info
Start Date :
September 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 8 2023
Estimated Enrollment :
513 Patients enrolled
Trial Details
Trial ID
NCT04431544
Start Date
September 29 2020
End Date
November 8 2023
Last Update
November 13 2023
Active Locations (25)
Enter a location and click search to find clinical trials sorted by distance.
1
Grandview Medical Group Research
Birmingham, Alabama, United States, 35243
2
Banner University Medical Institute
Phoenix, Arizona, United States, 85006
3
St Jude Medical Center
Fullerton, California, United States, 92835
4
University California San Diego
La Jolla, California, United States, 92037